Clinical Trial Update: Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome [NA]

View source ↗

Summary

This update indicates a study of the iCan i3 continuous glucose monitoring system in patients with dumping syndrome and post-bariatric hypoglycemia is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dumping Syndrome
• Post-bariatric Hypoglycemia

Drugs mentioned

• iCan i3 Continuous Glucose Monitoring System

Snippet

Sponsor: Kaiser Clinic and Hospital | Conditions: Dumping Syndrome, Post-bariatric Hypoglycemia | NA | Status: RECRUITING